Bank of America’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
RI
BCM
TCM
FCM
WP
NI
TGI
Bank of America's TNGX Position: Q1 2026 in Review
Bank of America reduced its Tango Therapeutics (TNGX) stake by 32% in Q1 2026, selling an estimated $2.1M and leaving 327,144 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3226.
Bank of America first reported a position in TNGX in Q3 2020 and has held it in 20 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.
- Bank of America held 327,144 shares of Tango Therapeutics worth $6.84M as of Q1 2026.
- Bank of America sold 150,918 Tango Therapeutics shares in Q1 2026, an estimated $2.1M.
- Tango Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3226 holding.
- Bank of America first reported a position in Tango Therapeutics in Q3 2020 and has held it in 20 quarters since.
- 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.